Neurotransmitters are chemical messengers that have excitatory, inhibitory, and modulatory actions. Learn what they are and ...

New Mechanistic Insights Underscore Multiple Potential Roles for Elraglusib as an Immune Modulator in the treatment of ...

Sumit Sharma, MD, sat down with Sydney Crago of Modern Retina to discuss his presentation on the 3 tyrosine kinase inhibitors ...

In a report released today, Swayampakula Ramakanth from H.C. Wainwright maintained a Buy rating on Dianthus Therapeutics (DNTH – Research ...

Using neuroblastoma, which is typically refractory to checkpoint inhibitors, as a model system, these findings illustrate the potential to activate the immune system even in cancers that have not ...

“By improving antigen presentation and enhancing the activation of CD8+ cytotoxic T cells, we are paving the way for more effective immunotherapeutic strategies including combinations of elraglusib ...

An attempt by Merck & Co. to unlock the microsatellite stable (MSS) metastatic colorectal cancer market has ended in failure.

This is an important behavioral, pharmacological intervention study of the effects of the catecholamine reuptake inhibitor methylphenidate (MPH) on value-based decision-making using a combination of ...

Greater proportion of upadacitinib-treated patients attained near-complete skin clearance in the head and neck region.

The FDA gave the green light to levacetylleucine (Aqneursa) as a stand-alone treatment for Niemann-Pick disease type C (NPC), ...